Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ICON stock

Learn how to easily invest in ICON stock.

ICON PLC
NASDAQ: ICLR - USD
$229.19
- $1.87 ( - 0.81%)
DIAGNOSTICS & RESEARCH

ICON is a diagnostics & research business based in the US. ICON shares (ICLR) are listed on the NASDAQ and all prices are listed in US Dollars. ICON employs 41,150 staff and has a trailing 12-month revenue of around $7.7 billion.

How to buy ICON stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ICLR. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

ICON stock price (NASDAQ: ICLR)

Use our graph to track the performance of ICLR stocks over time.

ICON shares at a glance

Information last updated 2023-01-26.
Latest market close$231.05
52-week range$171.43 - $279.80
50-day moving average $209.03
200-day moving average $213.04
Wall St. target price$257.33
PE ratio 40.4634
Dividend yield $0 (0%)
Earnings per share (TTM) $5.74

Buy ICON stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy ICON stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ICON price performance over time

Historical closes compared with the close of $231.05 from 2023-01-26

1 week (2023-01-20) -0.16%
1 month (2022-12-27) 19.57%
3 months (2022-10-27) 20.48%
6 months (2022-07-27) -0.32%
1 year (2022-01-27) -9.98%
2 years (2021-01-27) 11.14%
3 years (2020-01-27) 34.47%
5 years (2018-01-26) 99.92%

Is ICON stock undervalued or overvalued?

Valuing ICON stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICON's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ICON's P/E ratio

ICON's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, ICON shares trade at around 40x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ICON's PEG ratio

ICON's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3268. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICON's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

ICON's EBITDA

ICON's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.

The EBITDA is a measure of a ICON's overall financial performance and is widely used to measure a its profitability.

ICON financials

Revenue TTM $7.7 billion
Operating margin TTM 10.95%
Gross profit TTM $1.5 billion
Return on assets TTM 3.02%
Return on equity TTM 5.73%
Profit margin 6.06%
Book value $100.91
Market capitalisation $19 billion

TTM: trailing 12 months

ICON share dividends

We're not expecting ICON to pay a dividend over the next 12 months.

Have ICON's shares ever split?

ICON's shares were split on a 2:1 basis on 12 August 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ICON shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ICON shares which in turn could have impacted ICON's share price.

ICON share price volatility

Over the last 12 months, ICON's shares have ranged in value from as little as $171.43 up to $279.8. A popular way to gauge a stock's volatility is its "beta".

ICLR.US volatility(beta: 1.06)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICON's is 1.0649. This would suggest that ICON's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ICON overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland. .

Frequently asked questions

What percentage of ICON is owned by insiders or institutions?
Currently 0.695% of ICON shares are held by insiders and 100.054% by institutions.
How many people work for ICON?
Latest data suggests 41,150 work at ICON.
When does the fiscal year end for ICON?
ICON's fiscal year ends in December.
Where is ICON based?
ICON's address is: South County Business Park, Dublin, Ireland, 18
What is ICON's ISIN number?
ICON's international securities identification number is: IE0005711209
What is ICON's CUSIP number?
ICON's Committee on Uniform Securities Identification Procedures number is: 289900300

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site